Country for PR: United Kingdom
Contributor: PR Newswire Europe
Wednesday, May 13 2020 - 21:06
AsiaNet
Fluxergy Announces $30 Million to Expand Manufacturing Capacity of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19
IRVINE, California, May 13, 2019, /PRNewswire-AsiaNet/--

Irvine, California-based Fluxergy LLC, a diagnostic test company, is making a 
$30 million investment to expand its capability to scale production of the 
Fluxergy Analyzer diagnostic testing system in response to the COVID-19 
pandemic. 

The Fluxergy system, utilizing state-of-the-art PCR and microfluidics 
technology, has been shown to accurately identify the SARS-CoV-2 virus in one 
hour in studies conducted by the company, and by physician-scientists at the 
University of California San Diego. Fluxergy has started additional validation 
studies at world-leading health systems and plans to continue making its 
testing platform available as a Research Use Only (RUO) system for suitable 
partners during the current public health emergency. 

"We anticipate that our significant investment to step up our manufacturing 
capability will enable Fluxergy to deliver as many as one million tests per 
month by the end of 2020, reflecting our confidence in our technology as an 
innovative solution to COVID-19 testing shortages," said Dr. Ali Tinazli, Chief 
Commercial Officer of Fluxergy.

Fluxergy recently filed a request for an Emergency Use Authorization (EUA) with 
the U.S. Food and Drug Administration (FDA) to permit medical sites with 
CLIA-certified high complexity laboratories to begin using the company's 
high-speed test system for COVID-19 in accordance with the scope of FDA's 
authorization.

About Fluxergy

Fluxergy, launched in 2013 with funding support of principal investor and 
Kingston Technology co-founder John Tu, seeks to provide a portable, easy to 
use sample-to-answer POC platform that enables clinicians to cost-effectively 
conduct a wide range of multiplex and multimodal in vitro diagnostic tests 
(different types of tests all at once, up to 30 targets). Visit fluxergy.com 
for more information.

Photo - https://mma.prnewswire.com/media/1167640/FluxergyAnalyzerSystem.jpg 
Photo - 
https://mma.prnewswire.com/media/1167641/Fluxergy_Co_Founder_President.jpg

CONTACT: Dr. Ali Tinazli, atinazli@fluxergy.com +1 (310) 467-1112

Source: Fluxergy